德展健康(000813.SZ)擬7.7億元收購長江脈70%股權
格隆匯3月23日丨德展健康(000813.SZ)公佈,公司為進一步豐富公司產品線,通過投資驅動加速大健康產業鏈的佈局,經公司第七屆董事會第二十一次會議審議通過,公司於2020年3月23日與自然人戴彥榛、北京長江脈醫藥科技有限責任公司(“長江脈”)在北京市朝陽區簽署《德展大健康股份有限公司、戴彥榛、北京長江脈醫藥科技有限責任公司共同簽署的投資協議》,收購自然人戴彥榛持有的北京長江脈醫藥科技有限責任公司70%股權,交易價格為7.7億元人民幣。
目標公司的經營範圍為:清洗劑、消毒劑的生產;(以上限分支機構經營);醫療、保健、化工產品技術開發、轉讓;經濟信息諮詢(不含中介服務);勞務服務;維修機械設備;技術推廣服務;銷售醫療器械(限Ⅰ類、Ⅱ類)、衞生用品、化粧品、機械設備;貨物進出口、代理進出口、技術進出口;銷售第三類醫療器械。(企業依法自主選擇經營項目,開展經營活動;依法須經批准的項目,經相關部門批准後依批准的內容開展經營活動;不得從事本市產業政策禁止和限制類項目的經營活動。)
隨着全社會對醫療衞生安全等衞生事業的關注與重視程度不斷提升,國家管理日趨成熟,市場消費快速升級,長江脈公司迎來了事業發展的戰略機遇期。長江脈公司專注現代消毒科技二十多年,在現代消毒各領域進行了全面創新,是我國首家消毒科技創新企業,其生產的‘健之素’系列消毒用品已成為行業內的主導產品,廣泛用於公共衞生、醫療保健、食品飲料飲水工業、社會服務業、軍隊、鐵路、民航、學校等各個行業及家庭、差旅等民用市場。長期來看,長江脈公司有望發展成為該行業的頭部企業,此次投資有利於公司拓寬產品管線,開拓新的利潤增長點,提升公司綜合競爭力和盈利能力,加快公司發展速度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.